Eversept Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,603,348
Closed -$77.7M 77
2022
Q4
$77.7M Buy
1,603,348
+607,313
+61% +$26.7M 6.8% 4
2022
Q3
$37.9M Buy
996,035
+116,575
+13% +$5.19M 3.28% 9
2022
Q2
$44M Buy
+879,460
New +$46.7M 3.13% 10
2022
Q1
Sell
-38,672
Closed -$1.94M 105
2021
Q4
$1.94M Sell
38,672
-220,456
-85% -$10.9M 0.12% 81
2021
Q3
$12.5M Buy
+259,128
New +$13.2M 0.86% 33
2021
Q1
Sell
-68,138
Closed -$3.31M 96
2020
Q4
$3.31M Buy
68,138
+18,360
+37% +$906K 0.39% 39
2020
Q3
$2.5M Hold
49,778
0.55% 32
2020
Q2
$2.54M Sell
49,778
-139,800
-74% -$6.79M 0.35% 43
2020
Q1
$8.29M Sell
189,578
-252,083
-57% -$12.1M 2.06% 16
2019
Q4
$22.2M Buy
441,661
+201,661
+84% +$9.45M 3.92% 7
2019
Q3
$11.1M Sell
240,000
-26,062
-10% -$1.12M 3.45% 7
2019
Q2
$11.5M Sell
266,062
-66,340
-20% -$2.82M 3.22% 10
2019
Q1
$14.7M Buy
332,402
+26,160
+9% +$1.12M 4.29% 7
2018
Q4
$13.3M Buy
306,242
+25,370
+9% +$1.12M 7.2% 5
2018
Q3
$12.5M Buy
280,872
+67,900
+32% +$2.9M 5.51% 5
2018
Q2
$8.52M Buy
212,972
+75,000
+54% +$2.95M 3.9% 6
2018
Q1
$5.53M Sell
137,972
-50,000
-27% -$2.08M 2.57% 15
2017
Q4
$8.08M Buy
+187,972
New +$8.67M 4.65% 6

Other funds holding SNY

Eversept Partners's SNY Position: Q1 2023 in Review

Eversept Partners sold out of Sanofi (SNY) in Q1 2023, closing a stake of 1,603,348 shares — an estimated $77.7M sold.

Eversept Partners first reported a position in SNY in Q4 2017 and held it in 18 quarters. The position peaked at $77.7M in Q4 2022. 679 funds tracked by Wall St. Rank hold SNY as of Q1 2023.

  • Eversept Partners reported no remaining Sanofi position as of Q1 2023 after selling out during the quarter.
  • Eversept Partners sold 1,603,348 Sanofi shares in Q1 2023, an estimated $77.7M.
  • Eversept Partners first reported a position in Sanofi in Q4 2017 and held it in 18 quarters.
  • Eversept Partners's Sanofi position peaked at $77.7M in Q4 2022.
  • 679 funds tracked by Wall St. Rank held Sanofi as of Q1 2023.

Based on Eversept Partners's 13F filing for Q1 2023, filed 15 May 2023.